Navigation Links
Transgenomic Introduces SURVEYOR(R) Endonuclease Adaptor-Ligated Libraries (SEAL) for Determining Whole Genome Sequence Variation
Date:6/17/2008

al biotechnology company specializing in high sensitivity genetic variation and mutation analysis. The Company provides products and services in the fields of pharmacogenomics and pharmacogenetics.

Product offerings include the WAVE(R) DHPLC Systems and associated consumables specifically designed for use in genetic variation detection and single- and double-strand DNA/RNA analysis and purification. With broad applicability to genetic research, over 1600 systems have been shipped to customers in more than 30 countries. The SURVEYOR Mutation Detection Kits and SURVEYOR Check-It Kit provide reagents and protocols are for the detection of mutations in DNA. In addition, HANABI automated chromosome harvesting systems improve laboratory productivity with consistent quality compared to manual methods.

Service offerings include the Transgenomic Clinical Reference Laboratory, which provides reference laboratory services specializing in molecular diagnostics including Mitochondrial Disorders, Oncology and Hematology, Molecular Pathology and Inherited Diseases. Transgenomic Genomic Research Services is a CRO for pharmacogenomic, translational research and clinical trials.

FORWARD LOOKING STATEMENTS:

This document contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future results of operation or future financial performance, including, but not limited to the following statements: the Company's ability to develop, obtain regulatory approval and commercialize its clinical and preclinical product candidate programs. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our actual results to be materially different from these forward-looking statements. Factors which may significantly change or prevent our forward looking statements from fruition include that we may be unsuc
'/>"/>

SOURCE Transgenomic
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Webcast Alert: Transgenomic Inc. Announces First Quarter 2008 Earnings Release Conference Call Webcast
2. Transgenomic Opens Pharmacogenomics Laboratory in China
3. Reminder Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2007 Earnings Release Conference Call Webcast
5. Transgenomic Appoints David Pauluzzi to Board of Directors
6. Transgenomic, Inc. Forms Scientific Advisory Board
7. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2007 Earnings Release Conference Call Webcast
8. Transgenomic, Inc. Reports Second Quarter 2007 Results
9. Braemar Introduces the ER920W Wireless Cardiac Arrhythmia Monitor
10. LI-COR Biosciences Introduces Near-Infrared Small Animal Imager
11. SAFC Hitech Introduces Large Scale Bubbler for Compound Semiconductor Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... Patheon Inc ., a leading ... global pharmaceutical industry, will host a complimentary webinar on ... on Tuesday, June 4, 2013 at 11 a.m. Eastern ... to comply with regulations for cleaning validation. Many ... underpinning and little evaluation of risk. Some companies ...
(Date:5/23/2013)...  Rahal Letterman Lanigan Racing (RLL) and StemCyte, Inc., ... banking and therapeutics, announced today that StemCyte has become ... Indy car driven by James Jakes ... IndyCar 2013 season.   StemCyte, Inc. and Rahal ... of umbilical cord blood banking and its educational initiative ...
(Date:5/23/2013)... Auburn, MA (PRWEB) May 23, 2013 ... one inch wide and provide 15 mm travel ... nanometers. The small dimensions make these new ... in confined spaces. A vacuum rated version is ... Datasheet:, Drawings, specifications and datasheets can be found ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2
... OSLO, Norway, June 17 , ... Shown to Improve Remission Rates and,Reduce Short-Term Mortality Compared ... Pharma ASA (OSE: CLAVIS) today announces positive final results,from ... drug, elacytarabine,(CP-4055), in patients with late-stage acute myeloid leukaemia ...
... ... and Communications Convergence , ... San Diego, CA (PRWEB) June 17, 2009 -- CommNexus and Leap ... unlimited wireless services, today announce their support for EvoNexus, a non-profit incubator dedicated to ...
... by Advanced Cell Technology,s Chief Scientist, Robert Lanza yields answers ... 16 MSNBC.com featured today Dr. Robert Lanza,s book (co-authored ... Consciousness are the Keys to Understanding the True Nature of ... Log." The article by Science Editor Alan Boyle includes ...
Cached Biology Technology:Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 2Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 3Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 4Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 5Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 6Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia 7San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 2San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 3San Diego Wireless Heavyweight Leap Wireless Supports New Start-up Incubator 4MSNBC Publishes Free Online Abridgment of 'Biocentrism' 2MSNBC Publishes Free Online Abridgment of 'Biocentrism' 3
(Date:5/22/2013)... also conclude that the 20 percent reduction in ... versus chest X-ray (CXR) screening previously reported in ... screening centers in the United States. , Philadelphia, ... patients about the benefits and risks of LDCT ... New England Journal of Medicine of ...
(Date:5/22/2013)... major new effort to educate the public and decision ... clean water that looms ahead in the 21st century. ... current edition of Chemical & Engineering News , ... the world,s largest scientific society. , Bassam Z. Shakhashiri, ... Ph.D., explain that shortages of reliable supplies of fresh ...
(Date:5/22/2013)... health effects from disposal of millions of rechargeable ... recommend stronger government policies to encourage recovery, recycling ... the conclusion of a new paper in the ... , Oladele A. Ogunseitan and colleagues point out ... everything from smart phones to components in new ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
... Launches New Multi-Modal Biometric Identification Solution ... Enhanced Performance and Interoperability, SCHAUMBURG, Ill., March ... announced that it has been selected by the ... Biometric Identification,Solution (BIS). Motorola,s latest BIS solution features ...
... a genetic variant that can protect them after heart ... at Washington University School of Medicine in St. Louis ... effect that resembles that of beta blockers, drugs widely ... reason why beta blockers don,t appear to benefit some ...
... Researchers from The University of Arizona and Columbia University ... together and pull with forces far stronger than experts ... including Magdalene Maggie So, a member of the BIO5 ... College of Medicine, studied Type IV pili or ...
Cached Biology News:Motorola Biometric Identification System Selected by West Virginia State Police 2Many African-Americans have a gene that prolongs life after heart failure 2Many African-Americans have a gene that prolongs life after heart failure 3Many African-Americans have a gene that prolongs life after heart failure 4University of Arizona scientist shares in discovery of microbe filaments' power 2
... Analysis Note: Protein determined ... in 3.2 M (NH 4 ... pH 7.0 Preparation Note: Affinity ... sulfate suspension • Additives: MgCl ...
... PP2A, purified MW: 60kDa (A) and ... 20mM MOPS, pH 7.5, 500mM NaCl, ... 0.1mM MnCl2 1mM DTT, and 0.1mg/ml ... vitro dephosphorylation of proteins. Purification: DEAE ...
... Intracellular Localization Kit provides a straight forward ... of your design, in an efficient yet ... Subcellular localization and functional inhibition of target ... of the labeled siRNA into mammalian cells. ...
Selective media for Salmonella...
Biology Products: